North America Drug Screening Market – Industry Trends and Forecast to 2028

Market Analysis and Insights : North America Drug Screening Market

Drug screening market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 6,282.41 million and grow at a CAGR of 8.75% in the above-mentioned forecast period. The growing drug and alcohol consumption drives the drug screening market.

Drug testing is used to identify prescription drugs along with drugs used in plasma, semen and other biological samples, especially in offices, clinics, professional athletes, colleges or post-accidents. It is considered to be a critical part of ongoing diagnosis and treatment, whether deliberately or at will. Drug screening takes place at the time of a probable source, usually before a work or sporting event. Many illegal drugs include cocaine, morphine, amphetamine and cannabis, along with traditional psychoactive substances such as phenethylamines, ketamine and piperazine on the drug market.

Enforcement of stringent laws mandating drug and alcohol testing is the vital factor escalating the market growth, also rising presence of government funding in major markets, rising regulatory approvals and product launches and services, rising surge in funding for drug screening and increase in awareness against drug abuse are the major factors among others driving the drug screening market. Moreover, rising development of novel drug screening tests, oral fluid testing, rising emergence of fingerprint-based drug screening and emerging economies will further create new opportunities for drug screening market in the forecasted period of 2021-2028.

However, rising ban on alcohol consumption in several Islamic countries and prohibition of workplace drug testing in some countries are the major factors among others which will obstruct the market growth, while rising accuracy and specificity concerns related to breathalysers will further challenge the growth of drug screening market in the forecast period mentioned above.

This drug screening market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on drug screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Drug Screening Market Scope and Market Size

Drug screening market is segmented on the basis of sample type, condition, products and services and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of sample type, drug screening market is segmented into urine, breath, saliva, hair, blood, skin, oral fluid and others.
• Based on condition, the drug screening market is segmented into unconsciousness, panic attack, chest pain, drug allergies, breathing problem, seizures, organ transplant, pain management and others. 
• Based on products and services, the blood culture test market is segmented into analytical instruments, rapid testing devices, consumables and drug screening services. Analytical instruments have been further segmented into immunoassay analysers, chromatography instruments and breath analysers. Breath analysers have been further sub segmented into fuel cell breathalysers, semiconductor breathalysers and other devices. Rapid testing devices have been further segmented into urine testing devices and oral fluid testing devices. Urine testing devices have been further segmented into urine testing cups, dip cards and cassettes. Consumables have been further segmented into assay kits, sample collection cups, calibrators and controls and others.
• The drug screening market is also segmented on the basis of end-user into workplace and schools, criminal justice systems and law enforcement agencies, drug testing laboratories, drug treatment centers, hospitals, personal users and pain management centers.

Drug Screening Market Country Level Analysis

Drug screening market is analysed and market size insights and trends are provided by country, sample type, condition, products and services and end-user as referenced above.

The countries covered in the drug screening market report are U.S., Canada, and Mexico.  

The country section of the drug screening market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Drug screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for drug screening market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug screening market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Drug Screening Market Share Analysis

Drug screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to drug screening market.

The major players covered in the drug screening market report are Laboratory Corporation of America Holdings., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., MPD, Inc., Abbott, Drägerwerk AG & Co. KGaA, Alfa Scientific Designs, Inc., OMEGA LABORATORIES LTD, Premier Biotech, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Shimadzu Corporation, Psychemedics Corporation, Bayer AG, AstraZeneca, Sanofi, Pfizer Inc., GlaxoSmithKline plc., Merck & Co., Inc., and Johnson & Johnson Services, Inc. among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-1791